Universal Display has been granted a patent for ortho-substituted biphenyl compounds with bicarbazole linkages. These compounds are used in OLEDs and consumer products. GlobalData’s report on Universal Display gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on Universal Display, AMOLED displays was a key innovation area identified from patents. Universal Display's grant share as of January 2024 was 62%. Grant share is based on the ratio of number of grants to total number of patents.
Ortho-substituted biphenyl compounds for oleds
A recently granted patent (Publication Number: US11889708B2) discloses a compound of Formula I with various substituents, including hydrogen, deuterium, fluorine, and a range of alkyl and heteroalkyl groups. The compound can also form fused carbocyclic or heterocyclic rings. Additionally, the patent covers the use of this compound in an organic light emitting device (OLED) as part of the organic layer, along with other specified compounds like triazine and pyrimidine derivatives.
Furthermore, the patent extends to consumer products incorporating an OLED with the compound of Formula I in the organic layer. The OLED may include a phosphorescent emitter, specifically a transition metal complex with certain ligands. The patent also encompasses formulations containing the compound of Formula I, providing a broad scope for potential applications in various industries. Overall, the patent highlights the versatility and potential utility of the disclosed compound in OLED technology and consumer products.
To know more about GlobalData’s detailed insights on Universal Display, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.